Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | COMT | P21964 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12545076 | 0.87 | PLA2G10 (0.39) | LMNAMEN1KMT2AMAPTSMN1; SMN2 | |
| SCHEMBL12374391 | 0.85 | APP (0.41) | MEN1KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL12544949 | 0.81 | ESR1 (0.41) | LMNAMEN1KMT2AGAAMAPT | |
| SCHEMBL862821 | 0.80 | COMT (0.40) | LMNAMEN1KMT2AUSP2GAA | |
| SCHEMBL12545244 | 0.79 | PLA2G10 (0.36) | ESR1ESR2 | |
| SCHEMBL15599510 | 0.79 | LMNA (0.33) | LMNAMEN1KMT2AUSP2GAA | |
| SCHEMBL20806202 | 0.79 | COMT (0.39) | LMNAMEN1KMT2AUSP2GAA | |
| SCHEMBL11887463 | 0.78 | HSD17B1 (0.38) | LMNAMEN1KMT2AUSP2GAA | |
| SCHEMBL12374389 | 0.78 | ESR2 (0.36) | MEN1KMT2AMAPTALDH1A1ESR1 | |
| SCHEMBL12544768 | 0.76 | ESR1 (0.42) | LMNAMEN1KMT2AGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9331284-B2 | Polymer compound and light-emitting device using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20120326140-A1 | POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2012-12-27 | — | — | US | disclosed |
| US-20110187266-A1 | POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120326140-A1 | POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING SAME | CCNA1, CCNB1, CCNL2 | LMNA 668/4885MEN1 2260/4885KMT2A 817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.